On the origin of gastric tumours: analysis of a case with intramucosal gastric carcinoma and oxyntic gland adenoma

Most gastric cancers develop in inflamed gastric mucosa due to Helicobacter pylori infection, typically with metaplastic changes. However, the origins of gastric cancer remain unknown. Here, we present a case of intramucosal gastric carcinoma (IGC) and oxyntic gland adenoma (OGA) derived from spasmolytic polypeptide‐expressing metaplasia (SPEM). Early gastric cancer adjacent to a polyp was found in the upper corpus of a 71‐year‐old woman without H. pylori infection and was endoscopically resected. Histological examination showed IGC and OGA, both of which had predominant MUC6 expression. Interestingly, gastric glands with enriched MUC6‐positive mucous cells, referred to as SPEM, expanded between them. Whole‐exome sequencing analysis revealed a truncating KRAS(G12D) mutation in IGC, OGA, and SPEM. In addition, TP53 and CDKN2A mutations and a loss of chromosome 17p were found in the IGC, whereas a GNAS mutation was observed in the OGA. These results indicated that IGC and OGA originated from the KRAS‐mutated SPEM. © 2023 The Pathological Society of Great Britain and Ireland.

[1]  S. Ogawa,et al.  Expansion of gastric intestinal metaplasia with copy number aberrations contributes to field cancerization. , 2022, Cancer research.

[2]  J. Mills,et al.  Cellular Plasticity, Reprogramming, and Regeneration: Metaplasia in the Stomach and Beyond. , 2021, Gastroenterology.

[3]  J. Mills,et al.  Cellular plasticity at the nexus of development and disease , 2021, Development.

[4]  H. Ikeuchi,et al.  Frequent mutations that converge on the NFKBIZ pathway in ulcerative colitis , 2019, Nature.

[5]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[6]  J. Goldenring.  Pyloric metaplasia, pseudopyloric metaplasia, ulcer‐associated cell lineage and spasmolytic polypeptide‐expressing metaplasia: reparative lineages in the gastrointestinal mucosa , 2018, The Journal of pathology.

[7]  A. Rustgi,et al.  Metaplasia: tissue injury adaptation and a precursor to the dysplasia–cancer sequence , 2017, Nature Reviews Cancer.

[8]  M. Teh,et al.  Identification of Stem Cells in the Epithelium of the Stomach Corpus and Antrum of Mice. , 2017, Gastroenterology.

[9]  Takahiro Shimizu,et al.  Characterization of progressive metaplasia in the gastric corpus mucosa of Mongolian gerbils infected with Helicobacter pylori , 2016, The Journal of pathology.

[10]  S. Leach,et al.  Expression of Activated Ras in Gastric Chief Cells of Mice Leads to the Full Spectrum of Metaplastic Lineage Transitions. , 2016, Gastroenterology.

[11]  H. Tomita,et al.  Mist1 Expressing Gastric Stem Cells Maintain the Normal and Neoplastic Gastric Epithelium and Are Supported by a Perivascular Stem Cell Niche. , 2015, Cancer cell.

[12]  H. Kume,et al.  An empirical Bayesian framework for somatic mutation detection from cancer genome sequencing data , 2013, Nucleic acids research.

[13]  J. Mills,et al.  Tamoxifen induces rapid, reversible atrophy, and metaplasia in mouse stomach. , 2012, Gastroenterology.

[14]  T. Graham,et al.  The clonal origins of dysplasia from intestinal metaplasia in the human stomach. , 2011, Gastroenterology.

[15]  H. Hakonarson,et al.  ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data , 2010, Nucleic acids research.

[16]  M. Washington,et al.  Effect of Helicobacter pylori eradication on gastric carcinogenesis , 2008, Laboratory Investigation.

[17]  T. Tsukamoto,et al.  Effects of eradication of Helicobacter pylori on gastric carcinogenesis in experimental models , 2007, Journal of Gastroenterology.

[18]  P. Correa,et al.  A human model of gastric carcinogenesis. , 1988, Cancer research.